Dr. Timothy Triche is Chief of the Department of Pathology at Children’s Hospital Los Angeles and newly appointed Director of the Center for Personalized Medicine at CHLA. He also serves as Vice Chair, Department of Pathology and Professor of Pathology and Pediatrics at the Keck School of Medicine of the University of Southern California. Prior to joining Children’s Hospital, Dr. Triche was Head of Molecular Diagnostics at the National Cancer Institute. He is a Beckman Fellow of the Beckman Macular Research Center at the Doheny Eye Institute, and serves on the Board of Directors of LTC Properties Corporation, GenomeDx, Nanovalent, and Novellix. He is also a standing member of NCI Subcommittees C, D, and E, and serves as Associate Chair for Translational Research in Children’s Oncology Group. Professional memberships include the American Medical Association; United States and Canadian Academy of Pathology/Society for Pediatric Pathology; American Association for Cancer Research, and Association of Molecular Pathology (where he was a founding member of the solid tumor division). He also served as CEO and founder of OncorMed, a cancer predisposition company that developed several cancer predisposition tests, notably BRCA1 and 2, and several others.
He has been continuously NIH grant funded since joining USC/CHLA, including as PI on sequential NCI Director’s Challenge and SPECS awards totalling over $15 million, and has published over 200 articles in the peer reviewed literature. He has also established numerous collaborations with emerging biotechnology companies, has helped develop clinical applications for key technologies like microarrays, and is currently supporting biomedical application development of single-molecule ‘next gen’ DNA sequencing. Since 2004, Dr. Triche has been voted by his peers as one of the “Best Doctors in America.” He received his undergraduate degree in physics and biology from Cornell University in 1966 (where he was a Cornell National Scholar),MSTP program MD and PhD degrees from Tulane University in 1971, and his pathology training at Washington University, where he also did his post-doctoral fellowship with Dr. Stuart Kornfeld. After his residency, he undertook a fellowship in the Laboratory of Pathology at the National Cancer Institute, where he became a tenured staff member for 14 years.
